Pfizer Inc. PFE on Wednesday reported positive Phase 2 data for its investigational 25-valent pneumococcal conjugate vaccine ...

Pfizer Inc. today announced data from its Phase 2 study (NCT06524414) evaluating the safety, tolerability and immunogenicity of a four-dose series of its investigational 25-valent pneumococcal ...

Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...

Five brave women have spoken to the Record and shared photographs of their serious health problems after years on the jab.

Kirsty Moore was diagnosed with a tumour in 2021, but despite four operations the mass has grown on her optic nerve - she has ...

A brave Scottish woman who was left with a bulging eye and a brain tumour after years of taking the contraceptive jab has ...

The European Commission has approved Hympavzi to treat certain patients with hemophilia A or hemophilia B who have inhibitors ...

The pharmaceutical powerhouse still faces plenty of patent challenges, but it got a big one out of the way, securing time and ...

Generics juggernaut Sun Pharma is pulling one lot of a chemotherapy drug in the United States as the issue of particulate ...

Pfizer’s Hympavzi receives European approval to treat adults and adolescents with haemophilia A or B with inhibitors: New York Thursday, May 14, 2026, 09:00 Hrs [IST] Pfizer Inc ...